These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36722655)

  • 41. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
    Tisdale JE; Rudis MI; Padhi ID; Svensson CK; Webb CR; Borzak S; Ware JA; Krepostman A; Zarowitz BJ
    J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics of procainamide in continuous ambulatory peritoneal dialysis.
    Sica DA; Yonce C; Small R; Cefali E; Harford A; Poynor W
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):59-64. PubMed ID: 2457560
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Block of activated and inactivated sodium channels by class-I antiarrhythmic drugs studied by using the maximum upstroke velocity (Vmax) of action potential in guinea-pig cardiac muscles.
    Kodama I; Toyama J; Takanaka C; Yamada K
    J Mol Cell Cardiol; 1987 Apr; 19(4):367-77. PubMed ID: 2441073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhancing effects of salicylate on tonic and phasic block of Na+ channels by class 1 antiarrhythmic agents in the ventricular myocytes and the guinea pig papillary muscle.
    Tanaka Y; Hisatome I; Miyamoto J; Urashima T; Ikeda K; Yamanouchi Y; Sasaki N; Kinugawa T; Ogino K; Igawa O; Yoshida A; Shigemasa C; Kurata Y; Sato R
    Biochim Biophys Acta; 1999 May; 1418(2):320-34. PubMed ID: 10320683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated guinea pig papillary muscle.
    Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Szénási G; Varró A; Nánási PP
    Gen Pharmacol; 1997 Aug; 29(2):275-80. PubMed ID: 9251913
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Disposition of procainamide and N-acetylprocainamide in protein-calorie malnutrition.
    Jung D; Nanavaty M; Prasad P
    Drug Metab Dispos; 1985; 13(3):359-63. PubMed ID: 2410212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Torsade de pointes induced by N-acetylprocainamide.
    Chow MJ; Piergies AA; Bowsher DJ; Murphy JJ; Kushner W; Ruo TI; Asada A; Talano JV; Atkinson AJ
    J Am Coll Cardiol; 1984 Sep; 4(3):621-4. PubMed ID: 6206104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Frequency-dependent effects of several class I antiarrhythmic drugs on Vmax of action potential upstroke in canine cardiac Purkinje fibers.
    Varro A; Elharrar V; Surawicz B
    J Cardiovasc Pharmacol; 1985; 7(3):482-92. PubMed ID: 2410678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Electrophysiological effects of dridocainide on isolated canine, guinea-pig and human cardiac tissues.
    Pankucsi C; Hegedüs M; Kovács A; Szénási G; Szemerédi K; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):520-8. PubMed ID: 8751081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrophysiological effects of OPC-88117, a new antiarrhythmic agent on papillary muscles and single ventricular myocytes isolated from guinea-pig hearts.
    Toyama J; Kodama I; Honjo H; Kamiya K
    Br J Pharmacol; 1989 Sep; 98(1):177-85. PubMed ID: 2553186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
    Gawrońska-Szklarz B; Górnik W; Kutrzeba J; Wójcicki J; Zakrzewski J
    Pol Tyg Lek; 1992 Oct 5-12; 47(40-41):921-3. PubMed ID: 1284448
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
    Okumura K; Waldo AL
    J Am Coll Cardiol; 1987 Jun; 9(6):1332-8. PubMed ID: 2438320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
    Gwilt M; Arrowsmith JE; Blackburn KJ; Burges RA; Cross PE; Dalrymple HW; Higgins AJ
    J Pharmacol Exp Ther; 1991 Jan; 256(1):318-24. PubMed ID: 1988662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quantitative structure activity studies of antiarrhythmic properties in a series of lidocaine and procainamide derivatives.
    Ehring GR; Moyer JW; Hondeghem LM
    J Pharmacol Exp Ther; 1988 Feb; 244(2):479-92. PubMed ID: 2450194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of an antiarrhythmic agent, carocainide, on action potentials of ventricular papillary muscle of the guinea-pig heart in vitro.
    Muramoto J; Hotokebuchi N; Nishi K
    Arch Int Pharmacodyn Ther; 1991; 312():27-38. PubMed ID: 1772338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Procainamide pharmacokinetics during extracorporeal membrane oxygenation.
    Vollmer NJ; Wittwer ED; Rosenbaum AN; Wieruszewski PM
    Perfusion; 2023 Mar; 38(2):409-413. PubMed ID: 34617854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trimethoprim alters the disposition of procainamide and N-acetylprocainamide.
    Kosoglou T; Rocci ML; Vlasses PH
    Clin Pharmacol Ther; 1988 Oct; 44(4):467-77. PubMed ID: 2458879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physiologically-Based Pharmacokinetic Modeling for Drug-Drug Interactions of Procainamide and
    Jeong YS; Balla A; Chun KH; Chung SJ; Maeng HJ
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30845766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of very rapid emit Qst methods for measuring serum procainamide and N-acetylprocainamide concentrations.
    Carnes CA; Coyle JD
    Pharmacotherapy; 1992; 12(1):40-4. PubMed ID: 1372425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
    Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
    Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.